Astellas: Extending Tender Offer For OSI To May 17
23 Abril 2010 - 5:34AM
Dow Jones News
Astellas Pharma Inc. (4503.TO) said Friday it will extend its
$3.5 billion tender offer for OSI Pharmaceuticals Inc. (OSIP) by
another three weeks to May 17, as OSI's strong share price
continues to frustrate its attempts at a takeover.
Astellas said OSI shareholders have so far tendered a total of
42,283 shares for purchase, accounting for about 0.07% of
outstanding shares.
Japan's No. 2 pharmaceutical maker by sales said it will
continue to offer $52 per share in its hostile tender offer for the
U.S.-based company, which it originally launched on March 1.
On Thursday, OSI shares closed at $58.66.
-By Kazuhiro Shimamura, Dow Jones Newswires; 813-6269-2790;
kazuhiro.shimamura@dowjones.com
Osi Pharmaceuticals (NASDAQ:OSIP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Osi Pharmaceuticals Inc. (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de OSI Pharmaceuticals Inc.